Lung Cancer
From the Journals
Clinical chest images power up survival prediction in lung cancer
“The results of this study demonstrate promising results supportive of the notion that combining clinical and imaging data points can help build a...
Feature
Fifth COVID shot recommended for patients with cancer
Conference Coverage
Preop nivolumab plus chemo ‘a quantum leap’ in NSCLC therapy
The combination resulted in significantly longer event-free survival.
Conference Coverage
‘Major advance’: Sotorasib benefit persists in KRAS+ NSCLC
The finding comes from an analysis of long-term follow-up data from the CodeBreaK100 trial.
Conference Coverage
International group identifies actions to improve lung cancer survival
Experts recommend confirming lung cancer diagnosis within 30 days of referral.
Sponsored Article.
Treatment of Unresectable Stage III Non-small Cell Lung Cancer
Conference Coverage
Biomarker testing gains momentum in NSCLC
The NCCN recommends biomarker testing for patients with newly diagnosed stage 4 NSCLC.
Conference Coverage
Better survival in older cancer patients who take metformin
“It is important to explore optimal dosages that significantly improve cancer outcomes to boost anticancer effect.”
Conference Coverage
Lung cancer in 2030: Expand genotyping
Improve the ability to treat patients based on risk level and expand the use of targeted therapies.
Conference Coverage
Weighing the complexity of pathological response in lung cancer
Future work should aim to standardize pathology assessment.
Conference Coverage
Pembro provides DFS benefit in early NSCLC
But more data are needed to understand the longer-term survival outcomes and the role of PD-L1 as a predictive marker for sensitivity to immune...